Please login or register first to view this content.
Otic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Pedmark Now Available to Reduce Risk of Cisplatin-Induced Hearing Loss in Children
Pedmark Approved for Pediatric Cisplatin-Associated Ototoxicity
FDA Issues Final Rule for Over-the-Counter Hearing Aids
Link Between Analgesics, Incident Tinnitus Explored in Women
FDA Rejects Pedmark NDA Again Citing Manufacturing Deficiencies
FDA Eases Access to Cheaper Over-the-Counter Hearing Aids
Watchful Waiting for Acute Otitis Media Often Not Followed in Primary, Acute Care Settings
Cisplatin-Induced Hearing Loss Up for Young Children With Cancer
Osteoporosis, Low Bone Density May Contribute to Hearing Loss
Tympanostomy-Tube Placement No Better for Recurrent Otitis Media
USPSTF: Evidence Lacking for Screening Seniors for Hearing Loss
FDA Clears Automated Ear Cleaning Device for Earwax Removal
Generic Version of Ciprodex Otic Suspension Now Available
Ear Precipitate Formation Following Otitis Externa Treatment
Pedmark Receives Priority Review for Prevention of Cisplatin-Induced Ototoxicity
FDA Clears TOMi Scope for Noninvasive Imaging of Middle Ear
FDA Approves Ear Tube Delivery System That Does Not Require General Anesthesia
MPR Weekly Dose Podcast: Episode 14